JULY 27 - 30, 2008

Orlando, FL

NNS is going GREEN!

to find out more...

WELCOME...

The National Neurotrauma Society (NNS), including the AANS/CNS Section on Neurotrauma & Critical Care and the Virginia Commonwealth University (VCU) School of Medicine, invite you to attend The 26th Annual National Neurotrauma Symposium at the Hilton in the Walt Disney World Resort in Orlando, Florida.

This three day scientific symposium, which draws expertise from medical and scientific communities, is especially designed for scientists, physicians, postdoctoral fellows, residents and graduate students.   The scientific program will span the gamut of clinical pathophysiology, treatment strategies, basic research models and molecular approaches involved in CNS neurotrauma.

 

Letter from the NNS President

Letter from the AANS/CNS Section Chair

Dear Colleague:

It is a great pleasure for me as the President of the National Neurotrauma Society (NNS) to invite members of the Society and other basic scientists and clinicians who are interested in neurotrauma research and clinical management of spinal cord, brain and peripheral nervous system injury to attend The 26th National Neurotrauma Symposium which will be held at the Hilton Walt Disney World Resort in Orlando (Lake Buena Vista), Florida from July 27-30th, 2008.

The National Neurotrauma Symposium is the premier annual meeting of the neurotrauma community and provides the opportunity for basic scientists, clinicians, and allied health workers to meet and discuss timely topics and questions related to pathophysiology and mechanisms of recovery from and treatment of spinal cord injury (SCI) and traumatic brain injury (TBI). This annual meeting facilitates the translation of basic science laboratory findings into clinical treatment strategies for patients. The development of effective new therapies for neurotrauma requires the combined efforts of researchers from a variety of disciplines including physiology, biochemistry, molecular biology, pharmacology, neurosurgery, emergency medicine and critical care, neurorehabilitation and others. While many of these research areas are represented by professional societies that convene their own annual meetings, the National Neurotrauma Symposium is unique in that the sole emphasis is on SCI and TBI. Thus, it fills the need for a focused meeting during which the latest in neurotrauma basic and clinical science can be presented and discussed with like-minded colleagues.

This year, the NNS is, for the first time, is partnering with the Joint Section on Neurotrauma & Critical Care of the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS) in the organization of the meeting. Accordingly, our program will include four breakout sessions devoted to clinical aspects associated with management of SCI and TBI. This will greatly enhance the translational nature of the meeting and make this a very unique type of meeting that has educational value to both basic and clinical neurotraumatologists.

So, please plan to join me for The 26th Annual National Neurotrauma Symposium including the AANS/CNS Section on Neurotrauma & Critical Care this summer. It promises to be a great meeting scientifically in a location that is attractive and includes many exciting attractions for neurotrauma scientists, clinicians and their families. I hope to see you in Orlando!!!

Sincerely,

Edward D. Hall, Ph.D.
President, National Neurotrauma Society

Dear Colleague:

I want to personally invite you to attend The 26th National Neurotrauma Symposium which will be held at the Hilton Walt Disney World Resort in Orlando (Lake Buena Vista), Florida from July 27-30, 2008.

This is the First Joint Symposium between the National Neurotrauma Society and the AANS/ CNS Section on Neurotrauma and Critical Care. Over the years, the NNS and the Section have been very involved with neurotrauma and critical care science, though for the most part separate. While the National Neurotrauma Society has traditionally been more about the laboratory science, through a joint effort with the Section, the scientific program committee has created specific clinical sessions for the practicing physician and neurotrauma nurse as well as the basic scientist to better understand the state of the art management of neurotrauma and critical care with both didactic sessions (Management of TBI, spinal cord injury, and intensive care) and hands on sessions (Spinal column trauma reconstruction, multimodality monitoring, and surgical management for brain trauma). The goal of this joint symposium is to create a better dialogue and collaboration between the clinicians and scientists that might "translate" into improved patient care in the future through the combined efforts of researchers from a variety of disciplines including physiology, biochemistry, molecular biology, pharmacology, neurosurgery, emergency medicine and critical care, neurorehabilitation and others. This first joint symposium is a wonderful opportunity to hear the most up to date clinical and basic science in neurotrauma and critical care in a relaxed and rich, collaborative environment.


I look forward to your joining me in Orlando for The 26th Annual National Neurotrauma Symposium including the AANS/CNS Section on Neurotrauma & Critical Care that will, for the attendee, provide an excellent opportunity for seeing what is new in neurotrauma with spectacular and convenient accommodations at Disney World with plenty of trauma-specific CME. A wonderful meeting opportunity as well as a wonderful family getaway. We look forward to seeing you there!

Sincerely,

David Adelson, MD
Chair, AANS/ CNS Section on Neurotrauma and Critical Care

EDUCATIONAL OBJECTIVES

The goals of the 2008 Symposium are:

1.   To provide a forum for the presentation, discussion and feedback regarding the most recent findings in neurotrauma research and to encourage the interaction between both those new in the field and those with extensive experience in this area.

 

2.   To present and discuss the findings of established neuroscientists engaged in other areas of research in order to encourage the participation in neurotrauma research of these experts as well as to provide the neurotrauma community the opportunity to incorporate these new ideas and concepts into their research.   

3.  To present and discuss the  state of the art clinical management of both brain and spine/ spinal cord injury to clinicians and neuroscientists in order to encourage  collaboration, communication, and participation in neurotrauma research  and translate those concepts into clinical trials and clinical practice to improve outcomes in patients with neural injuries.

4.   To provide hands on sessions for clinicians in the areas of brain and spine/ spinal cord injury to encourage the incorporation of the state of the art clinical techniques in reconstruction and multimodality monitoring in the care of the injured patient. 

5.  Describe the state of the art interventions, therapeutic strategies, and multimodality monitoring can be used to improve outcome after CNS trauma.

6 . Describe how  acute surgical intervention and later reconstruction can be utilized to improve the outcome of patients with traumatic brain and  spine/ spinal cord injury.


At the completion of this symposium, participants should be able to:

1.   Describe current concepts that guide clinical care of brain and spinal cord injury patients and the therapeutic targets for improved functional recovery in the future.

 

2.   Describe mechanisms that contribute to brain cell injury and death, and how age influences these processes after traumatic central nervous system (CNS) injury.

 

3. Describe interventions and therapeutic strategies that stimulate regeneration and improve outcome after CNS trauma and how they might interact with endogenous recovery mechanisms.

    

4. Describe how laboratory as well as clinical research is impacting patients with traumatic brain and spinal cord injury.


NNS 2008 PROGRAM COMMITTEE

David Adelson, MD, Children's Hospital of Pittsburgh

Helen Bramlett, PhD, University of Miami

Maria Crowe, PhD, VA Medical Center

Michael Fehlings, PhD, University of California, Los Angeles

Gary Fiskum, PhD, University of Maryland School of Medicine

Patrick Kochanek, MD, University of Pittsburgh

Johnathan Lifshitz, PhD, University of Kentucky

Geoffrey Manley, MD, PhD, University of San Francisco

Barclay Morrison, PhD, Columbia University

David Okonkwo, MD, PhD, UPMC Presbyterian Hospital

Linda Phillips, PhD, Virginia Commonwealth University

Phillip Popovich, PhD, Ohio State University

Mayumi Prins, PhD, University of California, Los Angeles

Ramesh Raghupathi, PhD, Drexel University College of Medicine

Douglas Smith, PhD, University of Pennsylvania

Frank Tortella, MD, Walter Reed Army Institute of Research

Alex Valadka, MD, University of Texas


CONTINUING EDUCATION ACCREDITATION & CREDIT


This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Virginia Commonwealth University School of Medicine (VCU) and the National Neurotrauma Society.  VCU is accredited by the ACCME to provide continuing medical education for physicians.  

Physicians may claim up to 18.5 hours in Type 1 or Type 2 CME on the Virginia Board of Medicine Continued Competency and Assessment Form required for renewal of an active medical license.

VCU designates this educational activity for a maximum of 18.5 AMA PRA Category 1 Credits TM .  Physicians should only claim credit commensurate with the extent of their participation in the activity.

PRESENTED BY

VCUEmblemCW
Virginia Commonwealth University School of Medicine (VCU)

 


WOMEN IN NEUROTRAUMA RESEARCH

Please click here for more information on Women in Neurotrauma Research (WiNTR).